Table 2.
HUVEC line | Responder type | Basal IL-8 production (ng/ml/106 cells) | LPS-mediated IL-8 production (ng/ml/106 cells) | IL-8 genotype |
---|---|---|---|---|
1 | I | 0·61 ± 0·12 | 10·87 ± 2·74 | TA |
2 | I | 0·92 ± 0·23 | 16·44 ± 2·67 | TA |
3 | I | 0·95 ± 0·19 | 16·38 ± 4·63 | TA |
13 | I | 0·54 ± 0·34 | 16·58 ± 2·09 | TT |
14 | I | 0·46 ± 0·33 | 18·70 ± 1·57 | AA |
5 | II | 0·38 ± 0·12 | 75·45 ± 7·98 | AA |
22 | II | 1·23 ± 0·33 | 58·45 ± 4·50 | TT |
26 | II | 1·12 ± 0·11 | 66·50 ± 9·76 | TA |
27 | II | 1·45 ± 0·33 | 64·87 ± 11·2 | TA |
29 | II | 1·88 ± 0·56 | 70·34 ± 12·0 | AA |
HUVEC: human umbilical vein endothelial cell; IL: interleukin; LPS: lipopolysaccharide.